CONSOLIDATED STATEMENTS OF EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Common Stock Class A Common Stock	Common Stock Class B-1 Common Stock	Common Stock Class B-2 Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive (Loss) Income	Total Stockholders'/Members' Equity	Noncontrolling Interest
Beginning Balance at Jan. 29, 2022	$ 2,255,819	$ 265				$ 2,133,821	$ 142,166	$ (2,238)	$ 2,274,014	$ (18,195)
Beginning Balance (in shares) at Jan. 29, 2022			227,187	37,791	37,791
Equity-based compensation expense (Note 6)	12,055					12,055			12,055
Net (loss) income	23,802						24,693		24,693	(891)
Foreign currency translation adjustment, net of tax	(1,598)							(1,598)	(1,598)
Issuance of common stock, net of tax withholdings	(2,371)					(2,371)			(2,371)
Issuance of common stock, net of tax withholdings (in shares)			291
Ending Balance at Apr. 30, 2022	2,287,707	265				2,143,505	166,859	(3,836)	2,306,793	(19,086)
Ending Balance (in shares) at Apr. 30, 2022			227,478	37,791	37,791
Beginning Balance at Jan. 29, 2022	2,255,819	265				2,133,821	142,166	(2,238)	2,274,014	(18,195)
Beginning Balance (in shares) at Jan. 29, 2022			227,187	37,791	37,791
Net (loss) income	37,258
Ending Balance at Jul. 30, 2022	2,279,146	266				2,103,176	180,315	(4,611)	2,279,146
Ending Balance (in shares) at Jul. 30, 2022			227,909	37,791	37,791
Beginning Balance at Jan. 29, 2022	2,255,819	265				2,133,821	142,166	(2,238)	2,274,014	(18,195)
Beginning Balance (in shares) at Jan. 29, 2022			227,187	37,791	37,791
Ending Balance at Jan. 28, 2023	2,381,477	266				2,152,342	232,967	(4,098)	2,381,477
Ending Balance (in shares) at Jan. 28, 2023			228,338	37,791	37,791
Beginning Balance at Apr. 30, 2022	2,287,707	265				2,143,505	166,859	(3,836)	2,306,793	(19,086)
Beginning Balance (in shares) at Apr. 30, 2022			227,478	37,791	37,791
Equity-based compensation expense (Note 6)	13,422					13,422			13,422
Net (loss) income	13,456						13,456		13,456
Foreign currency translation adjustment, net of tax	(775)							(775)	(775)
Investment in veterinary joint venture	(35,000)					(54,086)			(54,086)	$ 19,086
Issuance of common stock, net of tax withholdings	336	1				335			336
Issuance of common stock, net of tax withholdings (in shares)			431
Ending Balance at Jul. 30, 2022	2,279,146	266				2,103,176	180,315	(4,611)	2,279,146
Ending Balance (in shares) at Jul. 30, 2022			227,909	37,791	37,791
Beginning Balance at Jan. 28, 2023	2,381,477	266				2,152,342	232,967	(4,098)	2,381,477
Beginning Balance (in shares) at Jan. 28, 2023			228,338	37,791	37,791
Equity-based compensation expense (Note 6)	22,282					22,282			22,282
Net (loss) income	(1,892)						(1,892)		(1,892)
Foreign currency translation adjustment, net of tax	1,057							1,057	1,057
Unrealized loss on derivatives (Note 4), net of tax	(984)							(984)	(984)
Losses on derivatives reclassified to income (Note 4), net of tax	433							433	433
Issuance of common stock, net of tax withholdings	(1,253)	1				(1,254)			(1,253)
Issuance of common stock, net of tax withholdings (in shares)			727
Ending Balance at Apr. 29, 2023	2,401,120	267				2,173,370	231,075	(3,592)	2,401,120
Ending Balance (in shares) at Apr. 29, 2023			229,065	37,791	37,791
Beginning Balance at Jan. 28, 2023	2,381,477	266				2,152,342	232,967	(4,098)	2,381,477
Beginning Balance (in shares) at Jan. 28, 2023			228,338	37,791	37,791
Net (loss) income	(16,498)
Unrealized loss on derivatives (Note 4), net of tax	2,931
Losses on derivatives reclassified to income (Note 4), net of tax	794
Ending Balance at Jul. 29, 2023	2,414,764	268				2,196,235	216,470	1,791	2,414,764
Ending Balance (in shares) at Jul. 29, 2023			229,826	37,791	37,791
Beginning Balance at Apr. 29, 2023	2,401,120	267				2,173,370	231,075	(3,592)	2,401,120
Beginning Balance (in shares) at Apr. 29, 2023			229,065	37,791	37,791
Equity-based compensation expense (Note 6)	24,322					24,322			24,322
Net (loss) income	(14,606)						(14,606)		(14,606)
Foreign currency translation adjustment, net of tax	1,107							1,107	1,107
Unrealized loss on derivatives (Note 4), net of tax	3,915							3,915	3,915
Losses on derivatives reclassified to income (Note 4), net of tax	361							361	361
Issuance of common stock, net of tax withholdings	(1,456)	1				(1,457)			(1,456)
Issuance of common stock, net of tax withholdings (in shares)			761
Ending Balance at Jul. 29, 2023	$ 2,414,764	$ 268				$ 2,196,235	$ 216,470	$ 1,791	$ 2,414,764
Ending Balance (in shares) at Jul. 29, 2023			229,826	37,791	37,791